ICD-10 title: Pulmonary blastomycosis
ICD-10 B43.1 is a billable code used to indicate a diagnosis of icd-10 title: pulmonary blastomycosis.
Pulmonary blastomycosis is a fungal infection caused by the organism Blastomyces dermatitidis, primarily affecting the lungs but can disseminate to other organs. It is endemic in certain regions of North America, particularly near waterways. The infection typically occurs after inhalation of airborne spores, leading to a range of respiratory symptoms including cough, chest pain, and fever. In immunocompromised patients, such as those with HIV/AIDS or undergoing immunosuppressive therapy, the risk of severe disease increases significantly. Diagnosis is often confirmed through culture, serology, or histopathological examination of tissue samples. Treatment usually involves antifungal medications, with itraconazole and amphotericin B being the most commonly used agents. Early recognition and appropriate management are crucial to prevent complications, especially in vulnerable populations.
Detailed patient history, including exposure risks and immunocompromised status.
Patients presenting with respiratory symptoms and a history of exposure to endemic areas.
Consideration of co-morbid conditions that may affect treatment choices.
Pulmonary function tests and imaging studies to assess lung involvement.
Patients with chronic cough, hemoptysis, or pneumonia-like symptoms.
Documentation of lung imaging findings and response to antifungal therapy.
Used when a patient presents with respiratory symptoms and a suspected fungal infection.
Document the clinical rationale for the test and any relevant history.
Infectious disease specialists may require additional lab results for comprehensive management.
Common symptoms include cough, chest pain, fever, and difficulty breathing. In some cases, it may present similarly to pneumonia.
Diagnosis is typically made through a combination of clinical evaluation, imaging studies, and laboratory tests, including cultures and serological assays.
